Comparison of Patients With Nonobstructive Coronary Artery Disease With Versus Without Myocardial Infarction (from the VA Clinical Assessment Reporting and Tracking [CART] Program)

被引:14
作者
Kovach, Christopher P. [1 ]
Hebbe, Annika [2 ,3 ]
O'Donnell, Colin, I [2 ]
Plomondon, Mary E. [2 ]
Hess, Paul L. [1 ,2 ]
Rahman, Aref [4 ,5 ]
Mulukutla, Suresh [5 ]
Waldo, Stephen W. [1 ,2 ]
Valle, Javier A. [1 ,2 ,6 ]
机构
[1] Univ Colorado, Dept Med, Div Cardiol, Aurora, CO 80045 USA
[2] VA Eastern Colorado Hlth Care Syst, Dept Med, Aurora, CO 80012 USA
[3] Univ Colorado, Dept Biostat & Informat, Aurora, CO USA
[4] VA Pittsburgh Hlth Care Syst, Dept Med, Pittsburgh, PA USA
[5] Univ Pittsburgh, Dept Med, Div Cardiol, Pittsburgh, PA USA
[6] Michigan Heart & Vasc Inst, Ann Arbor, MI 48197 USA
关键词
QUALITY IMPROVEMENT; MEDICAL THERAPY; OUTCOMES; MORTALITY; INTERVENTION; ANGIOGRAPHY; ANGINA;
D O I
10.1016/j.amjcard.2021.01.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Comparisons of the outcomes of patients with myocardial infarction with nonobstructive coronary artery disease (MINOCA) and patients with nonobstructive coronary artery disease (CAD) without myocardial infarction (MI) are limited. Here we compare the outcomes of patients with MINOCA and patients with nonobstructive CAD without MI and assess the influence of medical therapy on outcomes in these patients. Veterans who underwent coronary angiography between 2008 to 2017 with nonobstructive CAD were divided into those with or without pre-procedural troponin elevation. Patients with prior revascularization, heart failure, or who presented with cardiogenic shock, STEMI, or unstable angina were excluded. After propensity matching, outcomes were compared between groups. The primary outcome was major adverse cardiovascular events (MACE: mortality, myocardial infarction, and revascularization) within one year: 3,924 patients with nonobstructive CAD and a troponin obtained prior to angiography were identified (n=1,986 with elevated troponin) and restricted to 1,904 patients after propensity-matching. There was a significantly higher risk of MACE among troponin-positive patients compared with those with a negative troponin (HR 2.37; 95% CI, 1.67 to 3.34). Statin (HR 0.32; 95% CI, 0.22 to 0.49) and ACE inhibitor (HR 0.49; 95% CI, 0.32 to 0.75) therapy after angiography was associated with decreased MACE, while P2Y12 inhibitor, calcium channel and beta-blocker therapy were not associated with outcomes. In conclusion, Veterans with MINOCA are at increased risk for MACE compared with those with nonobstructive CAD and negative troponin at the time of angiography. Specific medications were associated with a reduction in MACE, suggesting an opportunity to explore novel approaches for secondary prevention in this population. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 32 条
[21]   Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management [J].
Niccoli, Giampaolo ;
Scalone, Giancarla ;
Crea, Filippo .
EUROPEAN HEART JOURNAL, 2015, 36 (08) :475-481
[22]   Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease [J].
Paolisso, Pasquale ;
Bergamaschi, Luca ;
Saturi, Giulia ;
D'Angelo, Emanuela Concetta ;
Magnani, Ilenia ;
Toniolo, Sebastiano ;
Stefanizzi, Andrea ;
Rinaldi, Andrea ;
Bartoli, Lorenzo ;
Angeli, Francesco ;
Donati, Francesco ;
Rucci, Paola ;
Mattioli, Anna Vittoria ;
Taglieri, Nevio ;
Pizzi, Carmine ;
Galie, Nazzareno .
FRONTIERS IN PHARMACOLOGY, 2020, 10
[23]   Systematic Review of Patients Presenting With Suspected Myocardial Infarction and Nonobstructive Coronary Arteries [J].
Pasupathy, Sivabaskari ;
Air, Tracy ;
Dreyer, Rachel P. ;
Tavella, Rosanna ;
Beltrame, John F. .
CIRCULATION, 2015, 131 (10) :861-+
[24]   Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention Results From 588,398 Procedures in the National Cardiovascular Data Registry [J].
Peterson, Eric D. ;
Dai, David ;
DeLong, Elizabeth R. ;
Brennan, J. Matthew ;
Singh, Mandeep ;
Rao, Sunil V. ;
Shaw, Richard E. ;
Roe, Matthew T. ;
Ho, Kalon K. L. ;
Klein, Lloyd W. ;
Krone, Ronald J. ;
Weintraub, William S. ;
Brindis, Ralph G. ;
Rumsfeld, John S. ;
Spertus, John A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (18) :1923-1932
[25]   Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study [J].
Safdar, Basmah ;
Spatz, Erica S. ;
Dreyer, Rachel P. ;
Beltrame, John F. ;
Lichtman, Judith H. ;
Spertus, John A. ;
Reynolds, Harmony R. ;
Geda, Mary ;
Bueno, Hector ;
Dziura, James D. ;
Krumholz, Harlan M. ;
D'Onofrio, Gail .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (13)
[26]   Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines) [J].
Smilowitz, Nathaniel R. ;
Mahajan, Asha M. ;
Roe, Matthew T. ;
Hellkamp, Anne S. ;
Chiswell, Karen ;
Gulati, Martha ;
Reynolds, Harmony R. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2017, 10 (12)
[27]   Coronary Artery Spasm A 2009 Update [J].
Stern, Shlomo ;
Bayes de Luna, Antoni .
CIRCULATION, 2009, 119 (18) :2531-2534
[28]   CIGARETTE-SMOKING IS A MAJOR RISK FACTOR FOR CORONARY SPASM [J].
SUGIISHI, M ;
TAKATSU, F .
CIRCULATION, 1993, 87 (01) :76-79
[29]   Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association [J].
Tamis-Holland, Jacqueline E. ;
Jneid, Hani ;
Reynolds, Harmony R. ;
Agewall, Stefan ;
Brilakis, Emmanouil S. ;
Brown, Todd M. ;
Lerman, Amir ;
Cushman, Mary ;
Kumbhani, Dharam J. ;
Arslanian-Engoren, Cynthia ;
Bolger, Ann F. ;
Beltrame, John F. .
CIRCULATION, 2019, 139 (18) :E891-E908
[30]  
Thygesen K, 2012, CIRCULATION, V126, P2020, DOI [10.1093/eurheartj/ehs184, 10.1161/CIR.0b013e31826e1058, 10.1016/j.jacc.2012.08.001, 10.1016/j.gheart.2018.08.004, 10.1016/j.clinbiochem.2012.10.036, 10.1016/j.gheart.2012.08.001, 10.5603/KP.2018.0203]